Delivery Order SPE2DR25D9329-SPE2DR26FJUT8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on December 8, 2025, with an ultimate completion date of December 30, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was awarded on November 18, 2025, with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,567.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in single-dose vials. The contract, designated as delivery order 4570055827, operates under a firm fixed-price structure with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery...
- The Defense Logistics Agency (DLA) awarded a $13,919 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the vendor competed against other contractors in unrestricted federal...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $13,516.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for yellow fever vaccine (YF-VAX) products. The delivery order, awarded on November 18, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,340.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by November 28, 2025, and was awarded on November 5, 2025. DMS Pharmaceutical Group serves as the prime...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The award, issued on October 20, 2025, carries a ceiling value of $5,567.60 under a firm fixed-price delivery order structure with an ultimate completion date of November 10, 2025. This delivery order was issued without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 6, 2025, with an ultimate completion date of December 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $7,404.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of yellow fever vaccine (YF-VAX). This firm fixed-price delivery order, issued on October 30, 2025, carries an ultimate completion date of October 30, 2025, and was awarded without a set-aside designation, demonstrating the contractor's competitive capability...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in...
- SPE2DR25D9329Indefinite Delivery Contract
- SPE2DR25D9329-SPE2DR26FJUT8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever vaccine (YF-VAX) vials. The award, issued on November 26, 2025, with an ultimate completion date of December 18, 2025, utilizes firm fixed-price delivery order terms under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. No set-aside designation was applied to this procurement, demonstrating the contractor's competitive capability in unrestricted federal pharmaceutical contracting. The place of performance is Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established under the DLA's PPV-G GEN V program, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. As a prime vendor contractor, DMS Pharmaceutical Group supplies an extensive portfolio including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring DoD medical supply requirements globally. The contractor has demonstrated substantial federal contracting activity through numerous recent delivery orders and maintains no identified subcontractor relationships in its award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 11/25/25 |